MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 6.67
+0.53 (8.63%)
Apr 20, 2026, 1:24 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 3.42 billion as of April 20, 2026. Its market cap has decreased by -13.68% in one year.
Market Cap
3.42B
Enterprise Value
3.76B
Revenue
712.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.67
Market Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 3.42B, a decrease of -22.08%. That is a compound annual growth rate of -10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.11B | 27.39% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 242.37B |
| Caliway Biopharmaceuticals | 168.09B |
| Lotus Pharmaceutical | 61.63B |
| Heron Neutron Medical | 61.19B |
| Shine-On BioMedical | 3.29B |
| SYN-TECH Chem. & Pharm. | 3.22B |
| BRIM Biotechnology | 3.19B |
| ShareHope Medicine | 3.06B |